Role of the Glycopeptide Framework in the Antibacterial Activity of Hydrophobic Derivatives of Glycopeptide Antibiotics
- 15 February 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (7), 1204-1209
- https://doi.org/10.1021/jm020320o
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Synthesis and Mode of Action of Hydrophobic Derivatives of the Glycopeptide Antibiotic Eremomycin and Des-(N-methyl-d-leucyl)eremomycin against Glycopeptide-Sensitive and -Resistant BacteriaJournal of Medicinal Chemistry, 2002
- Genetic Basis for Activity Differences Between Vancomycin and Glycolipid Derivatives of VancomycinScience, 2001
- The Role of Sugar Residues in Molecular Recognition by VancomycinJournal of Medicinal Chemistry, 2001
- Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide bindingFEMS Microbiology Letters, 2000
- Structure-Activity Relationships in the Series of Eremomycin Carboxamides.The Journal of Antibiotics, 2000
- Structural modifications of glycopeptide antibioticsMedicinal Research Reviews, 1997
- The Role of Hydrophobic Side Chains as Determinants of Antibacterial Activity of Semisynthetic Glycopeptide Antibiotics.The Journal of Antibiotics, 1997
- A Modification of the N-Terminal Amino Acid in me Eremomycin Aglycone.The Journal of Antibiotics, 1996